Posted by Vitreous Retina Macula Consultants of New York on 03/09/2022 in Other

Idiopathic Perifoveal Telangiectasia


Idiopathic Perifoveal Telangiectasis is commonly referred to as macular telangiectasia, a retinal disorder that affects the center most part of the macula. This poorly understood disease is most common in people between 40 to 60 years old. Dilated and leaky retinal capillaries develop around the temporal part of the foveal area and may eventually encompass the entire area, causing pigmentation to migrate below the retina and into the vitreoretinal interface. As this progresses, visual clarity decreases.

Telangiectasia Treatment

Unfortunately, there are no known treatments that have been successful in treating idiopathic perifoveal telangiectasia, but in certain cases, injection of anti-VEGF agents, such as Bevacizumab (Avastin), Lucentis, or Eylea may be beneficial.

Read more:

For more information about the Vitreous Retina Macula Consultants of New York, our doctors, or to schedule a consultation with Dr. Lawrence A. Yannuzzi, MD, please contact our ophthalmology practice by number: (212) 861-9797.

Working Hours:
Monday-Friday: 8am–5pm

Payment: cash, check, credit cards.

Vitreous Retina Macula Consultants of New York
950 3rd Ave 3rd floor,
New York, NY 10022
(212) 861-9797

Google maps:

Nearby Locations:
Lenox Hill | Upper East Side | Midtown East | Upper West Side
10021 | 10022 | 10023

Contact Member
category Other
Availability In Stock
View More Details

950 3rd Ave 3rd floor, New York, NY 10022

View On Larger Map